-
2023-507097-41-01
5
2025-03-20
Patients with limited-stage small cell lung cancer (LS-SCLC)
without
-
2024-513018-36-00
5
2025-03-06
Lung Diseases, Interstitial
-
2024-514517-35-00
5
2025-02-27
Acute myeloid leukemia
-
2023-507853-13-00
4
2025-02-25
Ulcerative Colitis
-
2024-511470-79-00
6
2025-02-11
Rheumatoid Arthritis
-
2024-518224-74-01
4
2025-02-07
metastatic non-small-cell lung cancer
-
2024-513317-12-00
5
2025-02-05
Pancreatic cancer
-
2024-513077-48-00
5
2024-12-19
O6-methylguanine methyltransferase (MGMT) unmethylated glioblastoma
-
2024-516874-31-00
5
2024-12-10
Patients with a low-grade serous epithelial carcinoma of the ovary (LG
-
2023-507717-94-00
5
2024-12-06
Deep partial and full-thickness burns
-
2023-503630-44-00
10
2024-11-20
Treatment of moderate-to-severe Atopic dermatitis
-
2024-512423-36-00
5
2024-11-20
Undifferentiated pleomorphic sarcoma
-
2022-501095-25-01
5
2024-11-04
Pediatric Subjects with Infantile-onset Pompe Disease Aged 0 to < 18 Y
-
2023-505606-42-00
5
2024-10-15
Head and Neck Squamous Cell Carcinoma (HNSCC)
-
2024-511404-17-00
5
2024-10-07
Unresectable or metastatic NRAS mutant cutaneous melanoma
-
2023-504231-41-01
10
2024-10-02
Locally advanced or metastatic urothelial cancer
-
2023-504445-31-00
4
2024-09-19
Carcinoma, Head and Neck
-
2023-508304-38-00
4
2024-09-10
Ulcerative Colitis (UC)
-
2022-502289-25-00
5
2024-08-28
Moderate to Severe Active Systemic Lupus Erythematosus
-
2023-504214-30-00
5
2024-06-27
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
-
2023-505775-70-00
4
2024-04-08
High risk smoldering multiple myeloma
-
2022-500795-62-00
4
2024-03-25
Eosinophilic gastritis
-
2023-506231-15-00
4
2024-02-22
Becker Muscular Dystrophy
-
2023-505486-92-00
4
2024-02-09
Small bowel adenocarcinoma